West Pharmaceutical Services
(NYSE) WST
West Pharmaceutical Services Financials at a Glance
Market Cap
$21.24B
Revenue (TTM)
$3.22B
Net Income (TTM)
$542.70M
EPS (TTM)
$7.48
P/E Ratio
40.20
Dividend
$0.87
Beta (Volatility)
0.90 (Low)
Dividend
$0.87
Beta (Volatility)
0.90 (Low)
Price
$300.44
Volume
224,454.39
Open
$299.35
Price
$300.44
Volume
224,454.39
Open
$299.35
Previous Close
$300.68
Daily Range
$298.45 - $301.42
52-Week Range
$202.79 - $322.34
Dividend
$0.87
Beta (Volatility)
0.90 (Low)
Price
$300.44
Volume
224,454.39
Open
$299.35
Previous Close
$300.68
Daily Range
$298.45 - $301.42
52-Week Range
$202.79 - $322.34
WST News
WST: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout West Pharmaceutical Services
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
10,800
CEO
Eric Mark Green, MBA
Website
www.westpharma.comHeadquarters
Exton, PA 19341-0645, US
WST Financials
Key Financial Metrics (TTM)
Gross Margin
36%
Operating Margin
21%
Net Income Margin
17%
Return on Equity
19%
Return on Capital
19%
Return on Assets
13%
Earnings Yield
2.49%
Dividend Yield
0.29%
Payout Ratio
11.39%
Stock Overview
Market Cap
$21.24B
Shares Outstanding
70.65M
Volume
224.45K
Avg. Volume
973.52K
Financials (TTM)
Gross Profit
$1.10B
Operating Income
$617.40M
EBITDA
$723.60M
Operating Cash Flow
$754.80M
Capital Expenditure
$285.90M
Free Cash Flow
$468.90M
Cash & ST Invst.
$791.30M
Total Debt
$416.70M
West Pharmaceutical Services Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$844.90M
+21.0%
Gross Profit
$296.40M
+27.4%
Gross Margin
35.08%
N/A
Market Cap
$21.24B
N/A
Market Cap/Employee
$2.00M
N/A
Employees
10,600
N/A
Net Income
$138.80M
+54.6%
EBITDA
$173.90M
+15.2%
Quarterly Fundamentals
Net Cash
$205.20M
+103.2%
Accounts Receivable
$685.60M
+26.1%
Inventory
$452.60M
+16.4%
Long Term Debt
$294.80M
+4.8%
Short Term Debt
$21.40M
-1.8%
Return on Assets
13.21%
N/A
Return on Invested Capital
19.37%
N/A
Free Cash Flow
$47.20M
-18.8%
Operating Cash Flow
$89.90M
-30.5%